Bahl & Gaynor Inc Simulations Plus, Inc. Call Options Transaction History
Bahl & Gaynor Inc
- $19.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLP
# of Institutions
176Shares Held
15.2MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$77.2 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$60.7 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$36 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$28.3 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$20.1 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $636M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...